Document Detail


A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines.
MedLine Citation:
PMID:  12925849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fusion of tumor cells with antigen-presenting cells (APCs) has been proposed for the preparation of cancer vaccines. However, generation of these hybrids, using physical or chemical methods such as electrofusion or polyethylene glycol (PEG), has been difficult to standardize. Characterization of cell fusion has also been problematic because of difficulties in differentiating fusion from cell aggregation, leakage of cellular dyes and dendritic-cell (DC) phagocytosis of tumor material. In this report, we describe a new method to generate hybrid cell vaccines, based on gene transfer of a viral fusogenic membrane glycoprotein (FMG) into tumor cells, and incorporate a genetic method by which true hybrid formation can be unambiguously detected. We describe a new class of tumor cell-DC hybrid that can be rapidly isolated after cell fusion. These hybrids are highly potent in in vitro antigen presentation assays, target lymph nodes in vivo and are powerful immunogens against established metastatic disease.
Authors:
Vy Phan; Fiona Errington; S Chiat Cheong; Tim Kottke; Michael Gough; Sharon Altmann; Annick Brandenburger; Steve Emery; Scott Strome; Andrew Bateman; Bernard Bonnotte; Alan Melcher; Richard Vile
Related Documents :
701379 - Flagellar membrane agglutination and sexual signaling in the conditional gam-1 mutant o...
11813199 - Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluore...
21330319 - Expression and effects of inhibition of igf-ir tyrosine kinase in mantle cell lymphoma.
3299749 - General protocol for microcell-mediated chromosome transfer.
9007089 - Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human t cell...
9151849 - Virus-like particle-induced fusion from without in tissue culture cells: role of outer-...
1665299 - Inflammatory cell influx into ozone-exposed guinea pig lung interstitial and airways sp...
22891069 - Regulation of glucose metabolism in t cells: new insight into the role of phosphoinosit...
22098869 - A constrained mixture approach to mechano-sensing and force generation in contractile c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2003-08-17
Journal Detail:
Title:  Nature medicine     Volume:  9     ISSN:  1078-8956     ISO Abbreviation:  Nat. Med.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-01     Completed Date:  2003-11-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9502015     Medline TA:  Nat Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1215-9     Citation Subset:  IM    
Affiliation:
Molecular Medicine Program, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, Neoplasm
Cancer Vaccines / genetics*,  immunology,  pharmacology
Cell Fusion / methods
Dendritic Cells / cytology*,  physiology
Genetic Techniques*
Glycoproteins / genetics
Hybrid Cells
Lymph Nodes / pathology
Melanoma / genetics,  pathology,  therapy
Mice
Mice, Inbred C57BL
Receptors, Antigen, T-Cell / genetics,  immunology,  metabolism
T-Lymphocytes / immunology
Tumor Cells, Cultured
Vaccination
Grant Support
ID/Acronym/Agency:
P50 CA91956/CA/NCI NIH HHS; R01 CA094180/CA/NCI NIH HHS; R01 CA85931/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm; 0/Cancer Vaccines; 0/Glycoproteins; 0/Receptors, Antigen, T-Cell

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
Next Document:  Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potenti...